TrialThe lancet. Diabetes & endocrinology2022

Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.

William V Tamborlane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.